ישראל - עברית - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate; sodium chloride - תמיסה להזרקה - sodium chloride 4.5 mg/ml; glucose as monohydrate 50 mg/ml - electrolytes - electrolytes - provides electrolytes and calories and is a source of water for hydration.

ישראל - עברית - Ministry of Health

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מסיסות בפה - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

ישראל - עברית - Ministry of Health

inovamed ltd - esomeprazole as magnesium trihydrate - esomeprazole as magnesium trihydrate 20 mg - esomeprazole

ישראל - עברית - Ministry of Health

inovamed ltd - esomeprazole as magnesium trihydrate - esomeprazole as magnesium trihydrate 40 mg - esomeprazole

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - lidocaine hydrochloride monohydrate; triamcinolone acetonide - פסטה - lidocaine hydrochloride monohydrate 3 g / 100 g; triamcinolone acetonide 0.1 g / 100 g - triamcinolone - triamcinolone - adjunctive treatment and temporary relief of symptoms associated with inflammatory lesions in the oral cavity.

ישראל - עברית - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - טבליה - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - ondansetron - for the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting in adults.

ישראל - עברית - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - טבליה - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - ondansetron - management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting in adults .

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - טבליות מצופות פילם - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.